Title
Date Published
How safe is blood, really?
January 15, 2010
Health economics of blood transfusion safety–focus on sub-Saharan Africa.
December 21, 2009
Clinical trials for pathogen reduction in transfusion medicine: A review
September 28, 2009
Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma
February 24, 2009
Transfusion-related mortality: The ongoing risks of allogeneic blood transfusion and the available strategies for their prevention.
February 2, 2009
Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
August 20, 2008
Effects of leukoreduced blood on acute lung injury after trauma: A randomized controlled trial.
April 21, 2008
Review: Incidence of bacterial transmission and transfusion reactions by blood components.
April 21, 2008
Proceedings of a consensus conference: pathogen inactivation-making decisions about new technologies.
January 1, 2008
Planning for pandemic influenza: effect of a pandemic on the supply and demand for blood products in the United States.
June 1, 2007
Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components.
May 22, 2007
Universal leukocyte reduction of transfused red cells does not provide benefit to patients undergoing cardiac surgery.
April 1, 2007
Leukoreduction Before Red Blood Cell Transfusion Has No Impact on Mortality in Trauma Patients.
December 8, 2006
Pathogen-reduction systems for blood components: The current position and future trends.
November 14, 2006
Electron micrographic study of the removal of Trypanosoma cruzi from blood products by leukodepletion filters.
July 1, 2006
Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery.
March 1, 2006
Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery.
March 1, 2006
Transfusion safety: where are we today?
November 1, 2005